Interest in the infant microbiome has grown enormously in the past decade, as research has revealed that the gut bacteria established in the first year of life have implications that extend far beyond digestion — into immune development, allergy risk, metabolic health, and even mental health outcomes. This is an active area of research with significant findings emerging regularly, and one where the practical implications for parents are beginning to become clear.
This article covers what is known about how the infant microbiome develops, what influences it in the first year, and what the evidence says about probiotic supplementation for babies.
Healthbooq tracks your baby's health alongside feeding and development — including logging any probiotic use and any changes in digestive symptoms that might help you and your healthcare provider assess whether an intervention is making a difference.
How the Gut Microbiome Develops
The microbiome of a newborn is established from the moment of birth and develops rapidly in the first months and years of life. The mode of delivery has a significant early effect: babies born vaginally are exposed to the mother's vaginal and gut microbiome during delivery; babies born by caesarean section are instead primarily colonised by skin and environmental bacteria. This difference in early colonisation has been associated with differences in allergy, asthma, and immune outcomes, though the long-term effect size and mechanisms are still being researched.
Breast milk is a major determinant of early microbiome composition. It contains not only the nutritional components the baby needs but also: human milk oligosaccharides (HMOs) — complex sugars that specifically feed certain beneficial bacteria and cannot be digested by the baby directly; maternal antibodies that shape immune responses; and living bacteria from the mammary gland and nipple that seed the baby's gut directly. This is one reason why the gut microbiome of breastfed babies differs substantially from that of formula-fed babies.
Antibiotic exposure — both perinatal (antibiotics given to the mother during labour or delivery) and in infancy — significantly disrupts the developing microbiome. Recovery after antibiotic courses can take months, and in some studies, repeated early antibiotic courses are associated with higher rates of allergy and metabolic outcomes. This is not a reason to avoid antibiotics when they are genuinely needed — the bacterial infection being treated is the more immediate risk. But it is a reason to avoid them when they are not indicated (for viral infections), and to support microbiome recovery after necessary courses.
Feeding Method and Solid Foods
The composition of breast milk feeds a specific community of gut bacteria, particularly Bifidobacterium species, which are dominant in the microbiome of breastfed babies and are associated with immune benefits and lower allergy risk. The microbiome of formula-fed babies, while less dominated by these species, is increasingly similar to breastfed babies' microbiomes as formula composition has improved. Partially hydrolysed and probiotic-supplemented formulas produce microbiome profiles that more closely approximate the breastfed profile.
The introduction of solid foods from around six months is one of the most significant microbiome events of the first year. The sudden availability of a diverse range of plant-based substrates — fibres that feed different bacterial species — drives a rapid diversification of the microbiome. The broader and more varied the diet in the first year and beyond, the greater the microbial diversity. Microbial diversity is consistently associated with better health outcomes across multiple domains.
Probiotics for Babies: What the Evidence Shows
Probiotic supplementation in infants — giving specific strains of bacteria in supplement form — has been studied for several purposes.
The most robust evidence is for Lactobacillus reuteri DSM 17938 in reducing colic symptoms in breastfed infants. Multiple randomised controlled trials have found that daily supplementation with this strain reduces crying time in colicky breastfed babies, with a meaningful effect size. The evidence is less consistent for formula-fed babies with colic.
Evidence for probiotics in preventing eczema and allergy is mixed and strain-specific. Some studies show benefit with certain Lactobacillus strains given in pregnancy or to the infant from birth; others show no benefit or effects only in specific subgroups. General recommendations for probiotic use in allergy prevention are not yet supported by sufficient consistent evidence.
Evidence for probiotics in reducing general infant infection rates or improving outcomes in healthy babies without specific indications is limited. The conclusion from the overall evidence is that probiotic supplementation for healthy babies without specific indications is probably harmless but probably also not meaningfully beneficial.
Key Takeaways
The gut microbiome — the community of bacteria, fungi, and other microorganisms in the digestive tract — develops rapidly in the first year of life and has long-term implications for immune function, metabolic health, and even mental health. Key early influences include mode of delivery, feeding method (breast milk vs formula), antibiotic exposure, and early food introduction. Probiotic supplementation has evidence for specific uses in infants — particularly Lactobacillus reuteri for colic reduction — but the evidence for general supplementation is more limited. The introduction of a diverse range of foods from around six months is one of the most impactful things parents can do to support microbiome diversity.
